Dublin, Dec. 11, 2025 (GLOBE NEWSWIRE) -- The "Smart In-Vitro Diagnostics Market - Artificial Intelligence for IVD Markets by Application, Technology and User, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering.
Revolutionizing the future of diagnostics, the integration of Smart Diagnostics and Artificial Intelligence (AI) is set to transform the healthcare landscape. With the industry progressing swiftly from a research phase to clinical applications, this transition promises to enhance diagnostic accuracy and effectiveness substantially. As healthcare providers strive to access comprehensive information to combat diseases, pharmaceutical companies recognize AI's potential to make therapies increasingly viable. Explore how these cutting-edge diagnostic approaches are poised to redefine medical care permanently.
This evolution presents a rapidly expanding market, as industry players vie for dominance in a field that is burgeoning from inception. Among these players, some are achieving significant advances and expanding their global footprint. The market dynamics are rife with opportunities, where the appropriate diagnostics paired with robust support can command premium pricing. Meanwhile, scientific developments are fostering new opportunities regularly, contributing to a downward trend in diagnostics costs.
This report is a valuable resource for analysts and planners, offering comprehensive data to inform strategic decisions. It includes hundreds of pages of crucial information, featuring an exhaustive list of United States Medicare Fee Payment Schedules, facilitating a deeper understanding of the latest pricing structures for nucleic acid-based tests. The report provides forecasts for demand across new testing regimes and technologies, aiding in research investment decisions and offering precise growth and market size estimates for emerging diagnostic technologies at no additional cost. Additionally, existing laboratories and hospitals can utilize this information to project and plan for expansion in clinical facilities.
Providing a thorough analysis, the report includes detailed breakouts for 18 countries and four regions, offering actionable insights tailored to specific geographies. Purchasers of the report can also request detailed breakouts for any country worldwide. This document is essential for those involved in strategic planning, offering a strategic advantage in navigating the evolving diagnostic market.
Companies Featured
- Ataraxis AI
- Tempus
- Evident
- Corista
- Sakura Finetek
- Visiopharm
- Viome Life Sciences
- Becton Dickinson
- Paige
- Leica Biosystems
- Clarapath
- Crosscope
- CanSense
- Owkin
- Guardant Health
- Lunit
- Vesale Bioscience
- Caris Life Sciences
- Numares Health
- DeepUll
- ADM Diagnostics
- Aiforia
- Thermo Fisher
- Adaptive Biotechnologies
- Aidoc
- Anumana
- ARUP Laboratories
- Atomwise
- Bayesian Health
- Behold.ai
- BGI Genomics Co. Ltd
- bioMerieux Diagnostics
- Bio-Rad Laboratories, Inc
- Cambridge Cognition
- Cardiologs (Phillips)
- CareDx
- Caris Molecular Diagnostics
- Cleerly
- ClosedLoop AI
- CloudMedX Health
- Deepcell
- Digital Diagnostics
- EKF Diagnostics Holdings
- Freenome
- GE Healthcare
- Glooko
- Idoven
- Illumina
- Infohealth
- Jade
- K Health
- MaxCyte
- Mayo Clinic Laboratories
- Medtronic
- Merative
- Nanox
- NIOX Group
- Niramai Health Analytix
- NVIDIA
- Oncohost
- OraLiva
- Oxford Nanopore Technologies
- Pacific Biosciences
- PathAI
- Perthera
- Philips Healthcare
- Prognos
- Qiagen
- Qure.ai
- Renalytix
- Seegene
- Siemens Healthineers
- Sophia Genetics
- Sysmex
- Viz.ai
For more information about this report visit https://www.researchandmarkets.com/r/d2gxsa
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
